These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 13573001)
1. Anti-Parkinson drugs and their relationship to glaucoma. EDWARDS CE; O'DOHERTY DS Bull Georgetown Univ Med Cent; 1958 Sep; 12(1):15-6. PubMed ID: 13573001 [No Abstract] [Full Text] [Related]
2. [Study of combined therapy of parkinsonian conditions, especially postencephalitic conditions]. KIRCHHOF JK Nervenarzt; 1956 Oct; 27(10):447-53. PubMed ID: 13387960 [No Abstract] [Full Text] [Related]
3. Parkinsonism: treatment with curare. BERGER H Ann Intern Med; 1956 Nov; 45(5):946-50. PubMed ID: 13373192 [No Abstract] [Full Text] [Related]
4. A study of the effectiveness of drug therapy in parkinsonism. KAPLAN HA; MACHOVER S; RABINER A J Nerv Ment Dis; 1954 May; 119(5):398-411. PubMed ID: 13192483 [No Abstract] [Full Text] [Related]
6. [An observation on the treatment of Parkinson's syndrome; results with the new drug ParKS 12]. HARDER A; PRELICZ T Schweiz Med Wochenschr; 1956 Mar; 86(13):335-8. PubMed ID: 13337189 [No Abstract] [Full Text] [Related]
7. [Experiences in the treatment of parkinsonism & other extrapyramidal disorders]. KONIG JK Medizinische; 1959 Feb; 4(9):388-9. PubMed ID: 13643481 [No Abstract] [Full Text] [Related]
9. Parkinsonism: drug therapy; neurosurgical therapy. O'DOHERTY DS; COOPER IS Postgrad Med; 1958 Dec; 24(6):681-6. PubMed ID: 13614064 [No Abstract] [Full Text] [Related]
10. Quantitative measurement of therapy in paralysis agitans. AGATE FJ; DOSHAY LJ; CURTIS FK J Am Med Assoc; 1956 Feb; 160(5):352-4. PubMed ID: 13278202 [No Abstract] [Full Text] [Related]
11. Preliminary study of a new anti-parkinson agent. DOSHAY LJ; CONSTABLE K; FROMER S Neurology; 1952; 2(3):233-43. PubMed ID: 14929300 [No Abstract] [Full Text] [Related]
12. Trihexyphenidyl (artane), stramonium, and nonchemotherapy of paralysis agitans. BERKOWITZ B; ALVERMANN E AMA Arch Neurol Psychiatry; 1952 Apr; 67(4):462-72. PubMed ID: 14914224 [No Abstract] [Full Text] [Related]
13. Five year follow-up of treatment with trihexyphenidyl (artane); outcome in four hundred eleven cases of paralysis agitans. DOSHAY LJ; CONSTABLE K; ZIER A J Am Med Assoc; 1954 Apr; 154(16):1334-6. PubMed ID: 13151847 [No Abstract] [Full Text] [Related]
14. Antispasmodic compound 08958 in treatment of paralysis agitans. MAGEE KR; DEJONG RN J Am Med Assoc; 1953 Oct; 153(8):715-8. PubMed ID: 13096281 [No Abstract] [Full Text] [Related]
16. [New methods of medicinal treatment of extrapyramidal disorders, with special reference to parkinsonism & postencephalitic parkinsonism]. RUTHER W; THEISS W Med Klin; 1958 Aug; 53(35):1495-7. PubMed ID: 13589544 [No Abstract] [Full Text] [Related]
17. Ethopropazine (parsidol) hydrochloride in treatment of paralysis agitans; posology, method of administration, and effects. DOSHAY LJ; CONSTABLE K; AGATE FJ J Am Med Assoc; 1956 Feb; 160(5):348-51. PubMed ID: 13278201 [No Abstract] [Full Text] [Related]
18. [Myographic and clinical observations on two new antihistaminics used in the treatment of parkinsonism]. STEGER R; HUFSCHMIDT HJ Dtsch Z Nervenheilkd; 1958; 178(4):413-30. PubMed ID: 13609390 [No Abstract] [Full Text] [Related]
19. Five-year study of benztropine (cogentin) methanesulfonate; outcome in three hundred two cases of paralysis agitans. DOSHAY LJ J Am Med Assoc; 1956 Nov; 162(11):1031-4. PubMed ID: 13366700 [No Abstract] [Full Text] [Related]
20. Treatment of Parkinsonism. GILLHESPY RO; BALESTRIERI A; SIGNORATO U Br Med J; 1958 Jun; 1(5086):1542. PubMed ID: 13546622 [No Abstract] [Full Text] [Related] [Next] [New Search]